Millions of people worldwide suffer from breast cancer, which can be emotionally and physically taxing to manage. Even though traditional treatments like radiation, chemotherapy, and surgery have saved many lives, they frequently have serious side effects that can lower a patient’s quality of life. Personalized medicine, which modifies treatment to each patient’s particular genetic, biological, and personal traits, has become a game-changer in recent years. By emphasizing targeted treatment, personalized medicine seeks to raise breast cancer patients’ overall quality of life in addition to increasing survival rates.
Personalized medicine: what is it?
Personalized medicine, also called precision medicine, describes medical procedures that base treatment decisions on a patient’s particular genetic, molecular, and environmental data. For breast cancer patients, this strategy frequently uses genomic testing on individuals to examine tumor DNA and find certain genetic mutations or biomarkers that accelerate the disease’s spread. By matching patients with specific medicines based on these biomarkers, oncologists can ensure that treatment is both minimally invasive and as effective as possible.
Genomic testing, for example, can determine whether a breast tumor is triple-negative, hormone receptor-positive, or HER2-positive. HER2-positive malignancies react favorably to treatments like trastuzumab (Herceptin) or pertuzumab because they overexpress the HER2 protein, which promotes fast tumor growth. Tamoxifen and aromatase inhibitors are examples of hormone-blocking drugs that can be used to treat hormone receptor-positive tumors, which depend on estrogen or progesterone for growth. Triple-negative breast tumors, on the other hand, do not have these receptors, although they might benefit from other cutting-edge treatments like immunotherapy or PARP inhibitors.
Breast cancer patients now have better results at every stage of their journey because of the paradigm shift from a one-size-fits-all treatment approach to a highly focused strategy brought about by these advancements in personalized medicine.
